API expert consensus document on management of ischemic heart disease.
Deshpande
Shantanu
S
Lokhandwala
Yash
Y
D017130:Angioplasty; D000069059:Atorvastatin; D002986:Clinical Trials as Topic; D017023:Coronary Angiography; D016527:Drug Costs; D050171:Dyslipidemias / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006538:Heptanoic Acids / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D007194:India; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000628:therapy*; D011758:Pyrroles / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D013300:Streptokinase